For the drug NEXIUM
describe briefly the normal cell biology, the pathogenic state and how the drug alters the pathogenic state. Remember - “a picture is worth a thousand words” – the use of a figure depicting a pathway map and indicating the point at which the drug acts is highly encouraged. Furthermore, you will develop and present an experimental plan by which you can prove where in the cell the drug acts; what cellular functions it modulates and the mechanism by which it works.The description of experimental techniques is needed
Fig: the drug alters the pathogenic state.
There are a few technical words that must be defined when relating neurotransmission to receptor action:
Agonist — a molecule that binds to a receptor protein and
activates that receptor
Competitive antagonist — a molecule that binds to the same site on
the receptor protein as the agonist, preventing activation of the
receptor
Non-competitive antagonist — a molecule that binds to a receptor
protein on a different site than that of the agonist, but causes a
conformational change in the protein that does not allow
activation.
There are two types of receptors that neurotransmitters interact with on a post-synaptic neuron. The first types of receptors are ligand-gated ion channels or LGICs. LGIC receptors are the fastest types of transduction from chemical signal to electrical signal. Once the neurotransmitter binds to the receptor, it will cause a conformational change that will allow ions to directly flow into the cell. The second types are known as G-protein-coupled receptors or GPCRs. These are much slower than LGICs due to an increase in the amount of biochemical reactions that must take place intracellularly. Once the neurotransmitter binds to the GPCR protein, it causes a cascade of intracellular interactions that can lead to many different types of changes in cellular biochemistry, physiology, and gene expression.
For the drug NEXIUM describe briefly the normal cell biology, the pathogenic state and how the...
1. According to the paper, what does lactate dehydrogenase (LDH) do and what does it allow to happen within the myofiber? (5 points) 2. According to the paper, what is the major disadvantage of relying on glycolysis during high-intensity exercise? (5 points) 3. Using Figure 1 in the paper, briefly describe the different sources of ATP production at 50% versus 90% AND explain whether you believe this depiction of ATP production applies to a Type IIX myofiber in a human....